NYS ADAP Includes New Hep C meds on Formulary

New York State AIDS Drug Assistance Program Adds First HCV Direct-Acting Antiviral (DAA) to its Formulary

Following successful pricing negotiations with Merck, AbbVie and Bristol Myers Squibb by the National ADAP Crisis Task Force, in which New York has a leadership role, the New York State Department of Health, AIDS Drug Assistance Program (ADAP) will be offering  access to the following Hepatitis C agents for participants in the state’s AIDS Drug Assistance Program:

  • Zepatier (Merck)
  • Viekira Pak
  • Viekira XR (AbbVie)
  • Daklinza (Bristol Myers Squibb)

This formulary addition is effective November 28, 2016.

©2019 HepFree.NYC. All rights reserved. Site by Lookit Design QuikSite®

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you. Thank you.

Sending
or

Log in with your credentials

Forgot your details?